Lessee, Operating Lease, Liability, Undiscounted Excess Amount in USD of IGC Pharma, Inc. from Q1 2020 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.
Summary
IGC Pharma, Inc. quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount history and change rate from Q1 2020 to Q1 2025.
  • IGC Pharma, Inc. Lessee, Operating Lease, Liability, Undiscounted Excess Amount for the quarter ending 31 Mar 2025 was $3,000.000, a 72.7% decline year-over-year.
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, Quarterly (USD)
Lessee, Operating Lease, Liability, Undiscounted Excess Amount, YoY Quarterly Change (%)

IGC Pharma, Inc. Quarterly Lessee, Operating Lease, Liability, Undiscounted Excess Amount (USD)

Period Value YoY Chg Change % Date Report Filed
Q1 2025 $3,000 -$8,000 -72.7% 31 Mar 2025 10-K 27 Jun 2025
Q1 2024 $11,000 -$20,000 -64.5% 31 Mar 2024 10-K 24 Jun 2024
Q1 2023 $31,000 -$26,000 -45.6% 31 Mar 2023 10-K 07 Jul 2023
Q4 2022 $60,000 -$7,000 -10.4% 31 Dec 2022 10-Q 14 Feb 2023
Q3 2022 $45,000 -$31,000 -40.8% 30 Sep 2022 10-Q 01 Nov 2022
Q2 2022 $84,000 $0 0% 30 Jun 2022 10-Q 05 Aug 2022
Q1 2022 $57,000 -$29,000 -33.7% 31 Mar 2022 10-K 23 Jun 2022
Q4 2021 $67,000 -$26,000 -28% 31 Dec 2021 10-Q 10 Feb 2022
Q3 2021 $76,000 -$27,000 -26.2% 30 Sep 2021 10-Q 29 Oct 2021
Q2 2021 $84,000 -$28,000 -25% 30 Jun 2021 10-Q 11 Aug 2021
Q1 2021 $86,000 -$37,000 -30.1% 31 Mar 2021 10-K 14 Jun 2021
Q4 2020 $93,000 31 Dec 2020 10-Q 16 Feb 2021
Q3 2020 $103,000 30 Sep 2020 10-Q 20 Nov 2020
Q2 2020 $112,000 30 Jun 2020 10-Q 19 Aug 2020
Q1 2020 $123,000 31 Mar 2020 10-K 13 Jul 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.